Federal Register / Vol. 65, No. 79 / Monday, April 24, 2000 / Notices 21769

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Agency for Toxic Substance and

Disease Registry

Public Meeting of the Inter-Tribal

Council on Hanford Health Projects

(ICHHP) in Association With the

Citizens Advisory Committee on Public

Health Service (PHS) Activities and

Research at Department of Energy

(DOE) Sites: Hanford Health Effects

Subcommittee

Name: Public meeting of the Intertribal Council on Hanford Health

Projects (ICHHP) in association with the

Citizens Advisory Committee on PHS

Activities and Research at DOE Sites:

Hanford Health Effects Subcommittee

(HHES).

Time and Date: 9 a.m.–4:30 p.m., May

17, 1999.

Place: Cavanaughs at Columbia

Center, 1101 North Columbia Center

Blvd., Kennewick, Washington 99336,

telephone: (509) 783–0611.

Status: Open to the public, limited

only by the space available. The meeting

room accommodates approximately 50

people.

Background: Under a Memorandum

of Understanding (MOU) signed in

October 1990 and renewed in November

1992 between ATSDR and DOE. The

MOU delineates the responsibilities and

procedures for ATSDR’s public health

activities at DOE sites required under

sections 104, 105, 107, and 120 of the

Comprehensive Environmental

Response, Compensation, and Liability

Act (CERCLA or ‘‘Superfund’’). These

activities include health consultations

and public health assessments at DOE

sites listed on, or proposed for, the

Superfund National Priorities List and

at sites that are the subject of petitions

from the public; and other healthrelated activities such as epidemiologic

studies, health surveillance, exposure

and disease registries, health education,

substance-specific applied research,

emergency response, and preparation of

toxicological profiles.

In addition, under an MOU signed in

December 1990 with DOE and replaced

by an MOU signed in 1996, the

Department of Health and Human

Services (HHS) has been given the

responsibility and resources for

conducting analytic epidemiologic

investigations of residents of

communities in the vicinity of DOE

facilities, workers at DOE facilities, and

other persons potentially exposed to

radiation or to potential hazards from

non-nuclear energy production and use.

HHS has delegated program

responsibility to CDC. Community

Involvement is a critical part of

ATSDR’s and CDC’s energy-related

research and activities and input from

members of the ICHHP is part of these

efforts. The ICHHP will work with the

HHES to provide input on American

Indian health effects at the Hanford,

Washington site.

Purpose: The purpose of this meeting

is to address issues that are unique to

tribal involvement with the HHES,

including a presentation and discussion

on the DOE Richland Indian Office,

update on tribal cooperative agreements,

and agency updates.

Matters to be Discussed: Agenda items

will include a dialogue on issues that

are unique to tribal involvement with

the HHES. This will include updating

tribal members of the cooperative

agreement activities in environmental

health capacity building and providing

support for tribal involvement in and

representation on the HHES. Agenda

items are subject to change as priorities

dictate.

Contact Persons for More Information:

Leslie C. Campbell, Executive Secretary

HHES, Division of Health Assessment

and Consultation, ATSDR, 1600 Clifton

Road, NE M/S E–56, Atlanta, Georgia

30333, telephone 1–888/42–ATSDR

(28737), fax 404/639–0654.

The Director, Management Analysis

and Services office has been delegated

the authority to sign Federal Register

notices pertaining to announcements of

meetings and other committee

management activities, for both the

Centers for Disease Control and

Prevention and the Agency for Toxic

Substances and Disease Registry.

Dated: April 18, 2000.

John Burckhardt,

Acting Director, Management Analysis and

Services Office, Centers for Disease Control

and Prevention.

[FR Doc. 00–10083 Filed 4–23–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Agency for Toxic Substance and

Disease Registry

Citizens Advisory Committee on Public

Health Service (PHS) Activities and

Research at Department of Energy

(DOE) Sites: Hanford Health Effects

Subcommittee

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Agency for Toxic

Substances and Disease Registry

(ATSDR) and the Centers for Disease

Control and Prevention (CDC) announce

the following meeting.

Name: Citizens Advisory Committee

on PHS Activities and Research at DOE

Sites: Hanford Health Effects

Subcommittee (HHES).

Times and Dates: 8:30 a.m.–5 p.m.,

May 18, 2000.

1 p.m.–4 p.m., May 19, 2000.

Place: Cavanaughs at Columbia

Center, 1101 North Columbia Center

Blvd., Kennewick, WA 99336.

Telephone: (509) 783–0611

Status: Open to the public, limited

only by the space available. The meeting

room accommodates approximately 100

people.

Background: Under a Memorandum

of Understanding (MOU) signed in

October 1990 and renewed in November

1992 between ATSDR and DOE. The

MOU delineates the responsibilities and

procedures for ATSDR’s public health

activities at DOE sites required under

sections 104, 105, 107, and 120 of the

Comprehensive Environmental

Response, Compensation, and Liability

Act (CERCLA or ‘‘Superfund’’). These

activities include health consultations

and public health assessments at DOE

sites listed on, or proposed for, the

Superfund National Priorities List and

at sites that are the subject of petitions

from the public; and other healthrelated activities such as epidemiologic

studies, health surveillance, exposure

and disease registries, health education,

substance-specific applied research,

emergency response, and preparation of

toxicological profiles. In addition, under

an MOU signed in December 1990 with

DOE and replaced by an MOU signed in

1996, the Department of Health and

Human Services (HHS) has been given

the responsibility and resources for

conducting analytic epidemiologic

investigations of residents of

communities in the vicinity of DOE

facilities, workers at DOE facilities, and

other persons potentially exposed to

radiation or to potential hazards from

non-nuclear energy production and use.

HHS has delegated program

responsibility to CDC.

Purpose: This subcommittee is

charged with providing advice and

recommendations to the Director, CDC,

and the Administrator, ATSDR,

regarding community, American Indian

Tribes, and labor concerns pertaining to

CDC’s and ATSDR’s public health

activities and research at this DOE site.

The purpose of this meeting is to receive

an update from the Inter-tribal Council

on Hanford Health Projects; to review

and approve the Minutes of the previous

meeting; to receive updates from

ATSDR and CDC; to receive reports

from the Outreach, Public Health

21770 Federal Register / Vol. 65, No. 79 / Monday, April 24, 2000 / Notices

Assessment, Public Health Activities,

and the Studies Workgroups; and to

address other issues and topics, as

necessary.

Matters To Be Discussed: Agenda

items include discussion on the

summary of Hanford Health Information

Network (HHIN) project, update on

Individual Dose Assessment (IDA)

project, and reports from agency and

work groups. Agenda items are subject

to change as priorities dictate.

Contact Persons for More Information:

Leslie C. Campbell, Executive Secretary

HHES, Division of Health Assessment

and Consultation, ATSDR, 1600 Clifton

Road, NE M/S E–56, Atlanta, Georgia

30333, telephone 1–888/42–

ATSDR(28737), fax 404/639–0654.

The Director, Management Analysis

and Services office has been delegated

the authority to sign Federal Register

notices pertaining to announcements of

meetings and other committee

management activities, for both the

Centers for Disease Control and

Prevention and the Agency for Toxic

Substances and Disease Registry.

Dated: April 18, 2000.

John Burckhardt,

Acting Director, Management Analysis and

Services Office, Centers for Disease Control

and Prevention.

[FR Doc. 00–10081 Filed 4–23–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

National Center for Health Statistics

(NCHS), Data Policy and Standards

Staff, Announces the Following

Meeting

Name: ICD–9–CM Coordination and

Maintenance Committee meeting.

Time and Date: 9 a.m.–5 p.m., May

11, 2000.

Place: The Health Care Financing

Administration, Multipurpose room,

7500 Security Boulevard, Baltimore,

Maryland.

Status: Open to the public.

Purpose: The ICD–9–CM Coordination

and Maintenance (C&M) Committee will

hold its first meeting of the calendar

year 2000 cycle on Thursday, May 11,

2000. The C&M meeting is a public

forum for the presentation of proposed

modifications to the International

Classification of Diseases, NinthRevision, Clinical Modification.

Matters to be Discussed: Agenda items

include:

Head injuries

Mammografic microcalcification

Myofascial pain syndrome

Stress Fracture

Periventricular leukomalacia

Posttraumatic wound infection versus

complicated open wound

Premature menopause

Update on the ICD–10–PCS coding

system

Thoracic aortic aneurysm repair

Lysis of adhesions

Penile plethysmography with nerve

stimulation

Percutaneous endoscopic

gastrojejunostomy (PEJ)

Spinal fusion for pseudoarthosis

Addenda

Contact Person for Additional

Information: Amy Blum, Medical

Classification Specialist, Data Policy

and Standards Staff, NCHS, 6526

Belcrest Road, Room 1100, Hyattsville,

Maryland 20782, telephone 301/458–

4106 (diagnosis), Amy Gruber, Health

Insurance Specialist, Division of Acute

Care, HCFA, 7500 Security Blvd., Room

C4–07–07, Baltimore, Maryland, 21244

telephone 410–786–1542 (procedures).

Notice: In the interest of security, the

H.C.F.A. has instituted stringent

procedures for entrance into the

building by non-government employees.

Persons without a government I.D. will

need to show a photo I.D. and sign-in at

the security desk upon entering the

building.

Notice: This is a public meeting.

However, because of fire code

requirements, should the number of

attendants meet the capacity of the room

the meeting will be closed.

The Director, Management Analysis

and Services Office, has been delegated

the authority to sign Federal Register

notices pertaining to announcements of

meetings and other committee

management activities, for both CDC

and the Agency for Toxic Substances

and Disease Registry.

Dated: April 18, 2000.

John Burckhardt,

Acting Director, Management Analysis and

Services Office, Centers for Disease Control

and Prevention (CDC).

[FR Doc. 00–10082 Filed 4–23–00; 8:45 am]

BILLING CODE 4160–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Government-Owned Invention;

Availability for Licensing: ‘‘Prostate

Cancer Therapeutic and in vitro

Diagnostic Method to Screen for the

Presence of Metastatic Prostate

Cancer—A Monoclonal Antibody

Specific to Prostate Cells’’

AGENCY: National Institutes of Health,

Public Health Service, DHHS.

ACTION: Notice.

SUMMARY: The invention listed below is

owned by an agency of the U.S.

Government and is available for

licensing in the U.S. in accordance with

35 U.S.C. 207 to achieve expeditious

commercialization of results of federally

funded research and development.

ADDRESSES: Licensing information may

be obtained by contacting J. R. Dixon,

Ph.D., at the Office of Technology

Transfer, National Institutes of Health,

6011 Executive Boulevard, Suite 325,

Rockville, Maryland 20852–3804

(telephone 301/496–7056 ext 206; fax

301/402–0220; E-Mail:

jd212g@NIH.GOV). A signed

Confidential Disclosure Agreement is

required to receive a copy of any patent

application.

SUPPLEMENTARY INFORMATION:

Invention Title: ‘‘Monoclonal

Antibodies to Prostate Cells’’.

Inventor: Dr. Ira H. Pastan (NCI).

USP SN: 5,489,525 [= DHHS Ref. No.

E–201–92/0]—Issued on February 6,

1996.

Abstract

Prostate Cancer is a disease affecting

approximately 1 million men in the

U.S.A., with an annual incidence of

around 179,000 and approximately

30,000 deaths per year. It is estimated

that one-third of men over 50 will

develop prostate cancer at some time in

their lives. Control of primary tumor by

surgical resection and/or radiation has

proven effective in a number of cases,

however, metastatic spread, primarily to

the bone, especially at late hormone

independent stages of the disease, has

been more difficult to control and

monitor. With the aging of the U.S.

population, it has been estimated that

the number of prostate cancer cases will

increase dramatically.

Technology

The technology disclosed in the

5,489,525 patent relates to a monoclonal

antibody which is capable of binding to

a cell surface differentiation antigen